Home/ Supplements/ Phosphorus/ Ionic Phosphorus 50,000 PPM

Ionic Phosphorus 50,000 PPM

product on market Liquid Good State Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Phosphorus is an essential mineral that supports bone mineralization and cellular energy production. There is strong evidence for its role in maintaining skeletal integrity and metabolic function. However, evidence coverage for this specific ionic formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ionic Phosphorus 50,000 PPM
Open Full PDF View on NIH DSLD →
Details

Label Data

0.5 mL
Serving Size
118
Servings
Mineral
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25 mg (4% DV)
Market median: 99.0mg (503 products) 13 studies (A:0, B:3)

Other Ingredients

reverse osmosis Water Phosphorus
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults: Take 10 drops daily with 6-8 oz water or juice. Children 4+: Take 5 drops daily with 4-6 oz water or juice. Do not take on an empty stomach. Must be diluted. Do not take without water.

Shake well before using.

Warnings & Precautions

Caution: Keep out of reach of children.

Always speak with your physician before using any dietary supplement. Do not use if tamper evident seal is broken or missing.

Formulation Notes

Good state is proud to follow Good Manufacturing Practices (GMP)

Ultra concentrate

Natural. Liquid.

Nano-ionic minerals.

Additional Information

Made in USA

Professional grade

For freshness after opening, store in a cool, dark place.

100% satisfaction guaranteed

Text Support +1-215-608-1124 X000H1FFE9 FBA USA

Metadata

Product Details

UPC / SKU8 57515 00362 6
DSLD Entry Date2022-10-24
Product TypeMineral
FormLiquid
DSLD ID276977
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.